162 related articles for article (PubMed ID: 31750853)
1. Biosensors and bioassays for determination of matrix metalloproteinases: state of the art and recent advances.
Lei Z; Jian M; Li X; Wei J; Meng X; Wang Z
J Mater Chem B; 2020 Apr; 8(16):3261-3291. PubMed ID: 31750853
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase activity assays: Importance of zymography.
Kupai K; Szucs G; Cseh S; Hajdu I; Csonka C; Csont T; Ferdinandy P
J Pharmacol Toxicol Methods; 2010; 61(2):205-9. PubMed ID: 20176119
[TBL] [Abstract][Full Text] [Related]
3. Advances in assays of matrix metalloproteinases (MMPs) and their inhibitors.
Cheng XC; Fang H; Xu WF
J Enzyme Inhib Med Chem; 2008 Apr; 23(2):154-67. PubMed ID: 18343899
[TBL] [Abstract][Full Text] [Related]
4. Assays of matrix metalloproteinases (MMPs) and MMP inhibitors: bioassays and immunoassays applicable to cell culture medium, serum, and synovial fluid.
Catterall JB; Cawston TE
Methods Mol Biol; 2003; 225():353-64. PubMed ID: 12769502
[No Abstract] [Full Text] [Related]
5. Matrix metalloproteinases in biologic samples.
Jones GT
Adv Clin Chem; 2014; 65():199-219. PubMed ID: 25233615
[TBL] [Abstract][Full Text] [Related]
6. Active MMPs captured by alpha 2 macroglobulin as a marker of disease activity in rheumatoid arthritis.
Tchetverikov I; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
Clin Exp Rheumatol; 2003; 21(6):711-8. PubMed ID: 14740449
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
[TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances.
Huang H
Sensors (Basel); 2018 Sep; 18(10):. PubMed ID: 30262739
[TBL] [Abstract][Full Text] [Related]
9. Array-based in situ fluorescence assay for profiling multiplex matrix metalloproteinases activities in tissue section.
Lei Z; Jian M; Wei J; Wang Y; Meng X; Wang Z
Anal Chim Acta; 2019 Oct; 1078():112-118. PubMed ID: 31358208
[TBL] [Abstract][Full Text] [Related]
10. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts.
Pifer MA; Maerz T; Baker KC; Anderson K
Am J Sports Med; 2014 May; 42(5):1211-8. PubMed ID: 24627579
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
O-Charoenrat P; Rhys-Evans PH; Eccles SA
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):813-20. PubMed ID: 11448356
[TBL] [Abstract][Full Text] [Related]
14. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
Séguier S; Gogly B; Bodineau A; Godeau G; Brousse N
J Periodontol; 2001 Oct; 72(10):1398-406. PubMed ID: 11699482
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix metalloproteinases: an overview.
Chakraborti S; Mandal M; Das S; Mandal A; Chakraborti T
Mol Cell Biochem; 2003 Nov; 253(1-2):269-85. PubMed ID: 14619979
[TBL] [Abstract][Full Text] [Related]
16. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
18. Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions.
Mittal R; Patel AP; Debs LH; Nguyen D; Patel K; Grati M; Mittal J; Yan D; Chapagain P; Liu XZ
J Cell Physiol; 2016 Dec; 231(12):2599-621. PubMed ID: 27187048
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors in the cervical mucus plug at term of pregnancy.
Becher N; Hein M; Danielsen CC; Uldbjerg N
Am J Obstet Gynecol; 2004 Oct; 191(4):1232-9. PubMed ID: 15507946
[TBL] [Abstract][Full Text] [Related]
20. Polarized Secretion of Matrix Metalloproteinases and Their Inhibitors by Retinal Pigment Epithelium Derived from Induced Pluripotent Stem Cells During Wound Healing.
Greene WA; Burke TA; Kaini RR; Por ED; Wang HC
J Ocul Pharmacol Ther; 2017 Apr; 33(3):132-140. PubMed ID: 28384031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
